Xenon Pharmaceuticals (FRA:XP0) Cyclically Adjusted Book per Share: €5.64 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XP0 Xenon Pharmaceuticals Inc FRA:XP0
25 GF Score
Price €51.50
! 4 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals Cyclically Adjusted Book per Share?

Xenon Pharmaceuticals FRA:XP0 -2.83% 25 Cyclically Adjusted Book per Share is €5.64 as of Jun. 2026. GuruFocus rates FRA:XP0 with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Xenon Pharmaceuticals's adjusted book value per share for the three months ended in Jun. 2026 was €11.146. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.64 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Xenon Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 33.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-22), Xenon Pharmaceuticals's current stock price is €51.50. Xenon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €5.64. Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 9.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Xenon Pharmaceuticals was 23.70. The lowest was 6.18. And the median was 15.97.


Xenon Pharmaceuticals  (FRA:XP0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=51.50/5.64
=9.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Xenon Pharmaceuticals was 23.70. The lowest was 6.18. And the median was 15.97.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Xenon Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Xenon Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Xenon Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals Cyclically Adjusted Book per Share Chart

Xenon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 2.74 3.78 4.45

Xenon Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 4.34 4.45 4.92 5.64

FRA:XP0 vs PTCT, CGON, LGND: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xenon Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


FRA:XP0
25GF Score
Xenon Pharmaceuticals Inc FRA:XP0
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xenon Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xenon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=11.146/133.5265*133.5265
=11.146

Current CPI (Jun. 2026) = 133.5265.

Xenon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 -5.158 101.765 -6.768
201612 3.378 101.449 4.446
201703 -6.060 102.634 -7.884
201706 -6.102 103.029 -7.908
201709 -6.085 103.345 -7.862
201712 1.687 103.345 2.180
201803 0.382 105.004 0.486
201806 1.397 105.557 1.767
201809 3.376 105.636 4.267
201812 3.262 105.399 4.133
201903 2.904 106.979 3.625
201906 2.577 107.690 3.195
201909 2.346 107.611 2.911
201912 2.694 107.769 3.338
202003 4.667 107.927 5.774
202006 4.607 108.401 5.675
202009 4.228 108.164 5.219
202012 3.841 108.559 4.724
202103 5.507 110.298 6.667
202106 5.031 111.720 6.013
202109 4.951 112.905 5.855
202112 9.295 113.774 10.909
202203 9.273 117.646 10.525
202206 11.943 120.806 13.201
202209 12.162 120.648 13.460
202212 10.882 120.964 12.012
202303 10.167 122.702 11.064
202306 9.364 124.203 10.067
202309 9.176 125.230 9.784
202312 11.290 125.072 12.053
202403 10.823 126.258 11.446
202406 10.363 127.522 10.851
202409 9.484 127.285 9.949
202412 9.434 127.364 9.890
202503 8.502 129.181 8.788
202506 7.144 129.892 7.344
202509 6.181 130.287 6.335
202512 6.209 130.366 6.360
202603 11.976 132.262 12.090
202606 11.146 133.527 11.146

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €5.64 mean?
Xenon Pharmaceuticals (FRA:XP0) has a Cyclically Adjusted Book per Share of €5.64 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Xenon Pharmaceuticals and its competitors.
Is Xenon Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Xenon Pharmaceuticals' current Cyclically Adjusted Book per Share is €5.64. Overall, Xenon Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Xenon Pharmaceuticals' Cyclically Adjusted Book per Share compare to PTCT and CGON?
Xenon Pharmaceuticals' Cyclically Adjusted Book per Share of €5.64 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Xenon Pharmaceuticals and its competitors. Xenon Pharmaceuticals's current Cyclically Adjusted Book per Share is €5.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xenon Pharmaceuticals stock overvalued right now?
Xenon Pharmaceuticals (FRA:XP0) has a current Cyclically Adjusted Book per Share of €5.64. The current Cyclically Adjusted Book per Share is €5.64. Xenon Pharmaceuticals' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Xenon Pharmaceuticals (FRA:XP0), the current Cyclically Adjusted Book per Share is €5.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xenon Pharmaceuticals Business Description

Other Exchanges XENE:USAXP0:Germany
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
25GF Score

Get the complete analysis for FRA:XP0

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.50
Price